Effect of Bandage Compliance on Upper Extremity Volume in Patients with Breast Cancer-Related Lymphedema


Ergin G., Sahinoglu E., KARADİBAK D., YAVUZŞEN T.

LYMPHATIC RESEARCH AND BIOLOGY, cilt.16, sa.6, ss.553-558, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1089/lrb.2017.0060
  • Dergi Adı: LYMPHATIC RESEARCH AND BIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.553-558
  • Anahtar Kelimeler: complex decongestive physiotherapy, bandage, breast cancer lymphedema, COMPRESSION THERAPY, ARM LYMPHEDEMA, DRAINAGE, SECONDARY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Complex decongestive physiotherapy (CDP) is an effective treatment for patients with breast cancer-related lymphedema (BCRL). Bandaging is an important component of CDP. Although the literature suggests that bandages must be kept on for about 24 hours, some patients cannot tolerate keeping them on for this length of time. Also, it has been observed that limb volume decreased in patients who did not keep bandages on for 24 hours in clinical trials. But there is no evidence that this reduction in time is statistically significant. Our purpose was to compare the effectiveness of bandage compliance for a longer or a shorter period on limb volume in patients with BCRL. Methods and Results: We retroprospectively reviewed the medical records of 39 patients who received CDP. Twenty-eight eligible patients were divided into two groups, group 1 (n=18) and group 2 (n=10), according to the average number of hours of bandage compliance, which was 13-24 and 7-12 hours, respectively. The primary outcome was the change in limb volume between groups. The values for the limb volumes showed a statistically significant decrease in both groups. There was no significant difference in volume reduction between the groups. Conclusion: This study shows that keeping bandages on for between about 12 and 24 hours has the same effect on patients with BCRL as receiving CDP.